Mutz Christopher sold ANIP
March 13, 2026 · Form 4 insider transaction
Mutz Christopher sold 3,162 shares of ANI Pharmaceuticals, Inc. at $71.64 per share, a transaction worth $226.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,162
Price
$71.64
Total value
$226.5K
InsiderMutz Christopher
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 13, 2026
Filing dateMarch 13, 2026
Shares owned after91,309
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.; The shares were sold in multiple trades at prices ranging from $70.27 to $72.62. The price reported above reflects the weighted average sales price.